CCR3 (ccr3_human)
FAMILY
Class A (Rhodopsin) Protein receptors Chemokine receptors CCR3
GENE
CCR3
ORGANISM
Human (Homo sapiens)
ALT. NAMES
C-C chemokine receptor type 3, C C CKR3, C-C CKR-3, CC-CKR-3, CCR-3, CCR3, CKR 3, CKR3, Eosinophil eotaxin receptor, CD193
SOURCE
SWISSPROT
SEQUENCE
| N-term | |||||||||
|
M
|
T
|
T
|
S
|
L
|
D
|
T
|
V
|
E
|
T
|
| 10 | |||||||||
|
F
|
G
|
T
|
T
|
S
|
Y
|
Y
|
D
|
D
|
V
|
| 20 | |||||||||
| TM1 | |||||||||
|
G
|
L
|
L
|
C
|
E
|
K
|
A
|
D
|
T
|
R
|
| 30 | |||||||||
|
A
|
L
|
M
|
A
|
Q
|
F
|
V
|
P
|
P
|
L
|
| 40 | |||||||||
|
Y
|
S
|
L
|
V
|
F
|
T
|
V
|
G
|
L
|
L
|
| 50 | |||||||||
|
G
|
N
|
V
|
V
|
V
|
V
|
M
|
I
|
L
|
I
|
| 60 | |||||||||
| ICL1 | TM2 | ||||||||
|
K
|
Y
|
R
|
R
|
L
|
R
|
I
|
M
|
T
|
N
|
| 70 | |||||||||
|
I
|
Y
|
L
|
L
|
N
|
L
|
A
|
I
|
S
|
D
|
| 80 | |||||||||
|
L
|
L
|
F
|
L
|
V
|
T
|
L
|
P
|
F
|
W
|
| 90 | |||||||||
|
I
|
H
|
Y
|
V
|
R
|
G
|
H
|
N
|
W
|
V
|
| 100 | |||||||||
| ECL1 | TM3 | ||||||||
|
F
|
G
|
H
|
G
|
M
|
C
|
K
|
L
|
L
|
S
|
| 110 | |||||||||
|
G
|
F
|
Y
|
H
|
T
|
G
|
L
|
Y
|
S
|
E
|
| 120 | |||||||||
|
I
|
F
|
F
|
I
|
I
|
L
|
L
|
T
|
I
|
D
|
| 130 | |||||||||
|
R
|
Y
|
L
|
A
|
I
|
V
|
H
|
A
|
V
|
F
|
| 140 | |||||||||
| ICL2 | TM4 | ||||||||
|
A
|
L
|
R
|
A
|
R
|
T
|
V
|
T
|
F
|
G
|
| 150 | |||||||||
|
V
|
I
|
T
|
S
|
I
|
V
|
T
|
W
|
G
|
L
|
| 160 | |||||||||
|
A
|
V
|
L
|
A
|
A
|
L
|
P
|
E
|
F
|
I
|
| 170 | |||||||||
| ECL2 | |||||||||
|
F
|
Y
|
E
|
T
|
E
|
E
|
L
|
F
|
E
|
E
|
| 180 | |||||||||
|
T
|
L
|
C
|
S
|
A
|
L
|
Y
|
P
|
E
|
D
|
| 190 | |||||||||
| TM5 | |||||||||
|
T
|
V
|
Y
|
S
|
W
|
R
|
H
|
F
|
H
|
T
|
| 200 | |||||||||
|
L
|
R
|
M
|
T
|
I
|
F
|
C
|
L
|
V
|
L
|
| 210 | |||||||||
|
P
|
L
|
L
|
V
|
M
|
A
|
I
|
C
|
Y
|
T
|
| 220 | |||||||||
|
G
|
I
|
I
|
K
|
T
|
L
|
L
|
R
|
C
|
P
|
| 230 | |||||||||
| ICL3 | TM6 | ||||||||
|
S
|
K
|
K
|
K
|
Y
|
K
|
A
|
I
|
R
|
L
|
| 240 | |||||||||
|
I
|
F
|
V
|
I
|
M
|
A
|
V
|
F
|
F
|
I
|
| 250 | |||||||||
|
F
|
W
|
T
|
P
|
Y
|
N
|
V
|
A
|
I
|
L
|
| 260 | |||||||||
|
L
|
S
|
S
|
Y
|
Q
|
S
|
I
|
L
|
F
|
G
|
| 270 | |||||||||
| ECL3 | TM7 | ||||||||
|
N
|
D
|
C
|
E
|
R
|
S
|
K
|
H
|
L
|
D
|
| 280 | |||||||||
|
L
|
V
|
M
|
L
|
V
|
T
|
E
|
V
|
I
|
A
|
| 290 | |||||||||
|
Y
|
S
|
H
|
C
|
C
|
M
|
N
|
P
|
V
|
I
|
| 300 | |||||||||
| H8 | |||||||||
|
Y
|
A
|
F
|
V
|
G
|
E
|
R
|
F
|
R
|
K
|
| 310 | |||||||||
|
Y
|
L
|
R
|
H
|
F
|
F
|
H
|
R
|
H
|
L
|
| 320 | |||||||||
| C-term | |||||||||
|
L
|
M
|
H
|
L
|
G
|
R
|
Y
|
I
|
P
|
F
|
| 330 | |||||||||
|
L
|
P
|
S
|
E
|
K
|
L
|
E
|
R
|
T
|
S
|
| 340 | |||||||||
|
S
|
V
|
S
|
P
|
S
|
T
|
A
|
E
|
P
|
E
|
| 350 | |||||||||
|
L
|
S
|
I
|
V
|
F
|
DIAGRAMS
7TM
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
Pick color:
Invitro Mutant Data: Increased binding/potency: >5-fold, >10-fold; Reduced binding/potency: >5-fold, >10-fold; No/low effect (<5-fold); and N/A
MUTATIONS
PHYSIOLOGICAL LIGANDS
CCL24 (Mouse), CXCL10 (Mouse), CCL7 (Human), CXCL10 (Rat), CXCL11 (Mouse), CCL13 (Human), CCL11 (Rat), CCL11 (Mouse), CCL8 (Human), CXCL10 (Human), CCL2 (Rat), CCL5 (Mouse), CCL5 (Human), CCL28 (Mouse), CXCL9 (Human), CCL24 (Human), CXCL9 (Mouse), CCL7 (Rat), CCL11 (Human), CCL28 (Human), CCL2 (Human), CCL26 (Human), CCL8 (Mouse), CCL7 (Mouse), CCL2 (Mouse), CXCL11 (Human), CCL15 (Human)
STRUCTURE MODELS
STRUCTURES
Found 1 structure(s) - view all details on the Structures page
PDBs: 7X9Y